A view to brevity: Brand Institute’s clear-eyed approach to naming AbbVie’s new eyesight drug Vuity badams Thu, 12/16/2021 […]

Gilead’s Yescarta in line for $1.5B sales in earlier lymphoma thanks to game-changing data, fast production turnaround: analyst […]

The emergence of the omicron variant of covid-19 serves as a stark reminder that while we have made […]

A warning has been issued to UK MPs from the head of NHS England that hospitalisations could exceed […]

Venetoclax is an oral once-daily treatment, which blocks the action of the B-cell lymphoma-2 protein, the presence of […]

Biogen hits the gas pedal on Aduhelm confirmatory trial, hoping to deliver results in 4 years badams Thu, […]

With the number of covid-19 cases from the Omicron SARS-CoV-2 variant rising exponentially in the UK, Boris Johnson, […]

Sleep disorders and insufficient sleep are major global problems contributing to,for example, increased health care costs and sick […]

Detecting lung cancer at an early stage: the HANSE Study, sponsored by the German Center for Lung Research […]

In this paper by Wennerholm and colleagues (BMJ 2019;367: l6131, doi:10.1136/bmj.l6131, published 20 November), the data in table […]